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Regulation of Human Separase
by Securin Binding and Autocleavage
Introduction
Cohesion between sister chromatids is required to allow
Irene C. Waizenegger,1,2
Juan F. Gime´nez-Abia´n,3,6 Dominik Wernic,4
and Jan-Michael Peters1,5
1Research Institute of Molecular Pathology the biorientation of chromosomes on the mitotic spindle
and is therefore essential for equal segregation of sisterDr. Bohr-Gasse 7
1030 Vienna chromatids in anaphase. Cohesion is mediated by a
chromosomal protein complex called cohesin [1]. In2 Boehringer Ingelheim Austria
Dr. Boehringer-Gasse 5-11 budding yeast, cleavage of the cohesin subunit Scc1/
Mcd1 is required and sufficient to dissolve cohesion [2,1120 Vienna
Austria 3]. Cohesin cleavage is mediated by Esp1/separase, a
member of the CD clan of cysteine proteases that also3 Centro de Investigaciones Biologicas
Consejo Superior de Investigaciones Cientificas comprises caspases [3]. In metaphase, separase is acti-
vated by the anaphase-promoting complex (APC), whichVelazquez 144
28006 Madrid mediates the ubiquitin-dependent degradation of the
separase inhibitor Pds1/securin [4, 5].Spain
4 Boehringer Ingelheim Ltd. Separase orthologs are also required for anaphase in
S. pombe, A. nidulans, C. elegans, and Drosophila [6–9].2100 Cunard Street
Laval, Quebec H7S 2G5 It was initially less clear whether separase is also re-
quired for anaphase in vertebrates, because the largeCanada
bulk of vertebrate cohesin is removed from mitotic chro-
mosomes in prophase by a mechanism that does not
depend on the APC and cohesin cleavage [10–13]. How-
ever, small amounts of cohesin remain on chromosomesSummary
until metaphase, and the cleavage of these complexes
is required for the initiation of anaphase [13, 14].Background: Sister chromatid separation is initiated by
separase, a protease that cleaves cohesin and thereby As in budding yeast, separase is also bound to a
regulatory protein through most of the cell cycle in otherdissolves sister chromatid cohesion. Separase is activated
by the degradation of its inhibitor securin and by the eukaryotes, and it is called Cut2 in S. pombe, Pimples
in Drosophila, and PTTG in vertebrates [15–17]. Althoughremoval of inhibitory phosphates. In human cells, sepa-
rase activation also coincides with the cleavage of sepa- these proteins are not similar in their sequences, their
APC-mediated degradation is required for anaphase inrase, but it is not known if this reaction activates
separase, which protease cleaves separase, and how all cases and for activation of human separase in vitro
[14]. Like budding yeast Pds1, these proteins thereforeseparase cleavage is regulated.
Results: Inhibition of separase expression in human function as separase inhibitors, but it remains unknown
by which mechanism they inactivate separase. All ofcells by RNA interference causes the formation of poly-
ploid cells with large lobed nuclei. In mitosis, many of these proteins are now called securins. Drosophila sep-
arase is also bound to a second protein called Three-these cells contain abnormal chromosome plates with
unseparated sister chromatids. Inhibitor binding experi- rows, which may correspond to the N-terminal domain
of separase in other species [8, 17].ments in vitro reveal that securin prevents the access
of substrate analogs to the active site of separase. Upon Genetic and biochemical evidence suggests that sec-
urins do not only inhibit separase but that their presencesecurin degradation, the active site of full-length sepa-
rase becomes accessible, allowing rapid autocatalytic is also required for proper separase activation. Like sep-
arase mutants, Cut2 mutants in S. pombe and Pimplescleavage of separase at one of three sites. The resulting
N- and C-terminal fragments remain associated and can mutants in Drosophila are unable to initiate anaphase
[15, 18], and human cells lacking securin contain onlybe reinhibited by securin. A noncleavable separase mu-
low amounts of separase, whose specific activity is re-tant retains its ability to cleave cohesin in vitro.
duced [19].Conclusions: Our results suggest that separase is re-
Although securin genes are essential for viability inquired for sister chromatid separation during mitosis in
fission yeast and Drosophila, budding yeast cells canhuman cells. Our data further indicate that securin inhib-
survive without securin at low temperatures and canits separase by blocking the access of substrates to
initiate anaphase with fairly normal timing, indicatingthe active site of separase. Securin proteolysis allows
that mechanisms other than securin degradation mustautocatalytic processing of separase into a cleaved
regulate separase activation [20, 21]. Phosphorylation ofform, but separase cleavage is not essential for sepa-
Scc1/Mcd1 by the Polo-kinase Cdc5 increases cohesinrase activation.
cleavage by separase and may therefore be one such
mechanism [22]. Also, mice and human cultured cells
lacking securin are viable [19, 23, 24], suggesting that5 Correspondence: peters@imp.univie.ac.at
also mammalian separase is regulated by additional6 Present address: Research Institute of Molecular Pathology, Vienna
A-1030, Austria. mechanisms. In Xenopus egg extracts, high cyclin-
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dependent kinase 1 activity inhibits sister chromatid
separation through inhibitory phosphorylation of sepa-
rase [25]. This modification alone is sufficient to inhibit
separase in the absence of securin binding and possibly
explains why mammalian cells lacking securin are
viable.
In human cells, separase activation at the onset of
anaphase does not only coincide with securin destruc-
tion and cohesin cleavage but also with the cleavage
of separase itself [14]. Separase cleavage occurs at at
least two closely spaced sites and separates the con-
served C-terminal catalytic domain of separase from
the N-terminal portion. The correlation between securin
destruction and cohesin and separase cleavage implies
that these events may be coregulated, but it is not known
how separase cleavage is controlled, which protease
cleaves separase, and if separase cleavage is required
for its activation or inactivation.
Here, we show that securin degradation activates sep-
arase to undergo autocatalytic cleavage that can occur
at one of three sites. The resulting separase fragments
remain associated with each other. Nevertheless, sepa-
rase cleavage is not essential for separase activation in
vitro. We also provide evidence that securin inhibits
separase by blocking access of substrates to the active
site of separase and that separase is required for sister
chromatid separation in human cells in vivo.
Results
Inhibition of Separase Expression in Human Cells
by RNA Interference
To obtain insight into the in vivo function of human
separase, we transiently transfected HeLa cells with
small interfering RNAs (siRNAs) derived from the human
separase cDNA. Separase levels were strongly reduced
18 hr after transfection with either one of two different
separase siRNAs, called 1/2 and 3/4, whereas mock
transfections or transfection with a reverse siRNA (5/6)
had only little effect on separase levels (Figure 1A). Two
days following transfection, securin levels also de-
creased (data not shown), but other proteins such as Figure 1. Inhibition of Separase Expression Causes Polyploidiza-
tion in Human Cellstubulin were not affected (Figure 1A). In dishes con-
(A) HeLa cells were transfected with either one of two differenttaining transfected cells increasing numbers of floating
separase siRNAs (1/2, 3/4), or with the inverse siRNA of 1/2 (5/6),cells were seen, DAPI-stained fixed material revealed
or with control mixture (H2O), or were left untreated. A total of 18many cells with apoptotic morphology, and immunoblot-
hr after transfection, total cell lysates were analyzed by immunoblot-ting experiments showed cleavage of the caspase sub-
ting with separase, PARP-3, and tubulin antibodies.
strate poly-ADP ribose polymerase. However, similar (B–I) (B, C, F) Three days after transfection, control cells show normal
apoptotic effects were observed in cells transfected with nuclear morphology, as revealed by DAPI staining (B), whereas sep-
arase RNAi cells contain larger nuclei that are either (C) rosette-reverse siRNA (Figure 1A and data not shown), and these
shaped or (F) lobed. (D, E, G, I) Calyculin A-induced PCC followedeffects suggest that apoptosis may be caused by the
by chromosome spreading and Giemsa staining reveals higher chro-RNA interference protocol and not by loss of separase
mosome numbers in the morphologically abnormal nuclei of (E, G,expression.
and I) separase RNAi cells than in the nuclei of (D) control cells. The
nucleus in (E) is near-tetraploid, and the nuclei in (G) and (I) are
near-octoploid. Cells were analyzed 84 hr after transfection.Loss of Separase Expression Induces Polyploidy
(H) Near-octoploid chromosome numbers are also seen in chromo-in Human Cells
some spreads from separase siRNA cells treated for 3 hr with noco-
Fluorescence microscopy revealed that, 3 days follow- dazole.
ing transfection with separase siRNAs, most cells were Images in (B)–(G) are at similar magnification (the scale bar repre-
sents 20 M). The scale bar in (H) represents 30 M.in interphase and contained nuclei that were highly ab-
normal in size and shape (Figures 1C and 1F), whereas
control transfected cells showed normal nuclear mor-
pholgy (Figure 1B). The nuclei were 1–3 times larger
Current Biology
1370
Figure 2. Inhibition of Separase Expression
Causes Abnormal Mitotic Chromosome
Figures
Chromosome spreads from mitotic HeLa
cells transfected with separase siRNAs were
analyzed by Giemsa staining. Chromosomes
were isolated either (A, C–H, J, and K) 12 hr
or (B and I) 24 hr after transfection. The scale
bar represents 20 M.
(A, B, C) Normal chromosome figures show-
ing a (A) side view and a ([B], left figure) polar
view of a metaphase plate, ([B], right figure)
segregating chromatids in anaphase, and (C)
cells that have just completed cytokinesis.
The arrows in (C) indicate the cytokinesis
furrow.
(D–K) Abnormal chromosome figures show-
ing (D–F) smaller metaphase plates, (H and I)
chromosomes in a metaphase-like plate that
appear to decondense, and (J and K) irregu-
larly shaped chromosome plates in which
chromosomes appear to decondense. Sister
chromatids have not separated in these ab-
normal chromosome figures (arrows in [I–K]).
(G) Decondensed chromatin from an in-
terphase cell in which two nuclei are con-
nected by chromatin bridges (indicated by
arrows).
than normal, and they were usually lobed or adopted later stages when many cells were dying. At this early
stage, separase levels were greatly reduced but werea rosette-like shape. To analyze if these abnormalities
coincided with an increase in ploidy, we analyzed chro- still detectable (Figure 1A). Some cells might therefore
still have contained sufficient amounts of separase formosomes in mitotic cells. Three days after transfection,
only very few mitotic cells could be observed, but some normal mitotic progression. Consistent with this possi-
bility, we observed some normal metaphase, ana-telo-mitotic cells could be recovered by the addition of noco-
dazole for 3 hr, followed by mitotic shake off. Chromo- phase, and early G1 figures in these preparations (Fig-
ures 2A–2C). However, 62% of all metaphase-likesome spreads of these cells showed a wide range of
chromosome numbers from near diploid to near octo- configurations showed highly abnormal morphologies,
whereas only 8% of all metaphases from mock-trans-ploid (Figure 1H), and this is consistent with the possibil-
ity that the increased nuclear size is caused by poly- fected cells showed abnormalities. Many figures were
seen that resembled metaphase plates in side viewsploidization. To test directly if cells with abnormally
shaped nuclei contained increased chromosome num- (Figures 2D and 2H) or polar views (Figures 2E, 2F, and
2I), but the chromosomes in these plates were arrangedbers, we treated cells 3 days after siRNA transfection
with calyculin A, a phosphatase inhibitor that induces closer to each other than normal (see Figure 2B for
comparison). These chromosome plates often had apremature chromosome condensation (PCC) of in-
terphase nuclei in a wide variety of cell lines [26]. When more disk-like shape and not the ring shape with a cen-
tral opening that is rather typical for the arrangement ofcells were fixed 2 hr after the induction of PCC and
spread onto slides, chromosomes could be visualized chromosomes in normal human metaphase plates. We
never observed sister chromatid separation in the ab-before nuclear envelopes had broken down. Under these
conditions, large lobed nuclei could clearly be seen to normal chromosome plates. Instead, we observed fig-
ures in which chromosomes had apparently begun tocontain abnormally high chromosome numbers, con-
firming that these nuclei are polyploid (Figures 1E and decondense without separating sister chromatids (Fig-
ure 2I), and more irregular mitotic figures apparently1G). The same specimens also contained chromosomes
from cells whose nuclear envelope had already broken decondensed without separating sister chromatids (Fig-
ures 2J and 2K). These observations are consistent withdown. Also, these figures contained near tetraploid to
near octoploid chromosome numbers (Figure 1I). the possibility that cells lacking sufficient amounts of
separase fail to separate sister chromatids properly but
nevertheless exit from mitosis and therefore decon-Inhibition of Separase Expression Blocks Sister
Chromatid Separation in Mitosis dense unseparated chromosomes.
To test if separase is required for sister chromatid sepa-
ration in human cells, we isolated mitotic separase RNAi Inhibition of Separase by Peptide Inhibitors
To address if separase cleavage is required for its activa-cells by shake off without prior nocodazole treatment
and analyzed the morphology of metaphase and ana- tion, we first used peptide inhibitors that can covalently
bind to the active site cysteine in separase. Many prote-phase chromosomes in spread preparations. For this
experiment, we used cells 12–24 hr after siRNA transfec- ases are regulated by controlling the access of sub-
strates to their active sites. We therefore reasoned thattion because it was difficult to recover mitotic cells at
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seems to be required, as human separase is not able
to cleave yeast Scc1/Mcd1 and yeast separase cannot
cleave human SCC1 (data not shown; F. Uhlmann, per-
sonal communication).
Analysis of Separase Activity by Peptide Inhibitors
To understand when separase’s active site is accessible,
we added the biotinylated amk inhibitors either prior, dur-
ing, or after activation of separase-securin complexes
in mitotic Xenopus extracts. Subsequently, we analyzed
inhibitor binding to separase by avidin blotting and sep-
arase activity in SCC1 cleavage assays. When biotinyl-
ated inhibitor was added to separase-securin complexes
before mitotic activation, the cleaved forms of separase
that are already present in these immunoprecipitates
were clearly detected by avidin blotting, whereas full-
length separase was only labeled very weakly (Figure
4A, lane 1). This result implies that the active site of full-
length separase is not accessible in separase-securin
complexes. When the inhibitor was washed away from
these complexes and securin was degraded in mitotic
extracts, active separase was recovered, further indicat-
Figure 3. A Peptide Inhibitor of Human Separase
ing that the inhibitor had not bound to full-length sepa-
(A) The structure of the acyloxymethyl ketone derivative of the hu-
rase in separase-securin complexes (Figure 4C, lane 2).man SCC1 cleavage site peptide, synthesized as a separase in-
When inhibitor was present during mitotic activationhibitor.
of separase-securin complexes in mitotic Xenopus ex-(B) Inhibition of human separase by the inhibitor shown in (A), Bio-
DREIMR-amk, and a similar derivative lacking the N-terminal biotin tracts, a very different result was obtained. In this case,
moiety (DREIMR-amk). Activated separase from HeLa cells was in- both full-length and cleaved forms of separase were
cubated with the indicated amounts of the inhibitors, washed, and strongly labeled with inhibitor (Figure 4A, lane 5), and
analyzed for its ability to cleave in vitro-translated full-length human
separase remained inactive (Figure 4C, lane 5) despiteSCC1-myc (arrowhead). The generation of a C-terminal SCC1 cleav-
the fact that securin had been destroyed (Figure 4B,age product was detected by immunoblotting with myc antibodies
bottom panel, lane 5). These observations imply that(arrows).
the active site of separase can also be accessible to
inhibitor, but only once securin is destroyed.
Yet another result was obtained when inhibitor wasthe ability of peptide inhibitors to bind to either full-
length or cleaved separase could indicate which of these added to separase after it had been activated by securin
degradation in mitotic extracts. In this case, most sepa-proteins represents an active enzyme.
We synthesized inhibitors based on the hexapeptide rase had been cleaved and only the resulting separase
fragments were labeled with inhibitor, whereas residualDREIMR, which represents amino acid residues P6– P1
in the first cleavage site of human SCC1 [13]. The N amounts of full-length separase were not (Figures 4A
and 4B, lanes 7). The inhibitor treatment abolished SCC1terminus of the peptide was either biotinylated or was
left unmodified, whereas the C terminus was modified cleavage under these conditions (Figure 4C, lane 7) and
thus confirmed the data shown in Figure 3B.to an acyloxymethyl ketone (amk; Figure 3A). Similar
inhibitors based on a cleavage site found in yeast Scc1/ Together, these observations show that the active site
cysteine of C-terminal separase cleavage fragments isMcd1 have previously been shown to bind to the active
site cysteine in yeast separase [3]. To analyze the effects accessible to inhibitors under all conditions, and these
data are consistent with the possibility that cleaved sep-of these inhibitors on separase activity, we immunopre-
cipitated separase from human HeLa cells arrested in arase is an active protease. In contrast, full-length sepa-
rase can only be bound by inhibitor if the inhibitor ismitosis, activated separase by securin degradation in
mitotic Xenopus egg extracts, and incubated the reiso- present while securin is degraded. These results sug-
gest that securin proteolysis may allow access of inhibi-lated separase with in vitro-translated human SCC1 ei-
ther in the presence or absence of the peptide inhibitors. tors to the active site of separase. Once bound, the
inhibitor might prevent autocatalytic processing of sep-Both the biotinylated and the nonbiotinylated peptides
inhibited SCC1 cleavage with an IC50 between 1 and arase into cleaved forms, which would otherwise occur
rapidly following securin proteolysis. According to this10 M (Figure 3B), whereas an unrelated fluoromethyl
ketone inhibitor of caspase V, Z-VK-X-(Biotin)-D-FMK, hypothesis, the residual full-length separase molecules
that are present after separase activation in mitotic ex-had no effect (data not shown). Human separase could
also be inhibited by amk and chloromethyl ketone deriv- tracts (Figure 4B, upper panel, lane 7) might not bind
inhibitor because they would represent inactive sepa-atives of the yeast Scc1/Mcd1 cleavage site (Figure S1)
at concentrations similar to the ones required to inhibit rase that is still bound to securin. Consistent with this
interpretation, some securin can still be detected in theyeast separase [3]. However, for recognition of physio-
logical protein substrates, more than this hexapeptide same fraction (Figure 4B, lower panel, lane 7).
Securin Binding Prevents the Access of Peptides
to the Active Site of Separase
We next analyzed if rebinding of securin to activated
separase prevents the binding of peptide inhibitors. Ac-
tivated separase bound an amount of recombinant puri-
fied securin that was similar to the amount detected in
inactive separase immunoprecipitates, despite the fact
that activated separase contained predominantly cleaved
separase (Figure 5A, compare lanes 1 and 4). This implies
that securin can also bind to cleaved separase. The re-
binding of securin to separase correlated with the com-
plete loss of separase activity in SCC1 cleavage assays
and indicated that securin inhibits separase by direct
binding (Figure 5B). A destruction box mutant of securin
that can not be ubiquitinated by the APC had the same
effect, whereas bovine serum albumin (BSA) used as a
control did not inhibit separase (Figure 5B). During the
preparation of this manuscript, Stemmann et al. [25]
showed similarly that recombinant securin can inhibit
purified separase.
We next analyzed if peptide inhibitors can still bind
to activated separase once securin has been rebound
(Figure 5C). We observed that no peptide labeling was
obtained if separase was preincubated with securin,
whereas preincubation with a recombinant purified
cyclin fragment had no effect. Conversely, the binding
of inhibitor to separase did not detectably reduce the
binding of securin to separase, indicating that securin
can bind to separase by contacting residues outside
the active site of separase.
The N- and C-Terminal Cleavage Products
of Separase Remain Bound to Each Other
To analyze if the separase cleavage products remain
associated with each other, we transiently coexpressed
Figure 4. Securin Proteolysis Allows Binding of Peptide Inhibitors
to Separase
(A–C) The yeast separase inhibitor Bio-SVEQGR-amk (Inh) or its
solvent DMSO was added to separase from HeLa cells either before
(lanes 1 and 3), during (lanes 5 and 6), or after (lanes 7 and 8)
activation in mitotic Xenopus extracts. Unbound inhibitor was
washed away, and the separase immunoprecipitates were analyzed
by (A and B) SDS-PAGE and blotting and in (C) activity assays.
Separase to which the inhibitor or DMSO had been added before
activation (lanes 1 and 3) was subsequently also incubated in mitotic
Xenopus extracts (lanes 2 and 4) and was analyzed as above. The
inhibitor was used at a concentration of 85 M when added before
or after separase activation. In Xenopus extracts, 750 M inhibitor
was used. At lower concentrations, separase could not be labeled,
possibly because these extracts contain 50 mg/ml protein. (A) The
binding of inhibitor to separase was analyzed by SDS-PAGE and
by detecting the inhibitor’s biotin moiety in avidin blots. The position
of full-length separase and its C-terminal cleavage products is
marked by an arrowhead and arrows, respectively. (B) Separase
(top panel) and securin (bottom panel) were analyzed by SDS-PAGE
and immunoblotting. The separase antibodies used are directed
against the C terminus of separase. The arrowhead and arrows
indicate full-length and cleaved separase, respectively, as in (A). (C)
Separase activity was analyzed in SCC1-myc cleavage assays as
in Figure 3B. The top panel shows full-length SCC1-myc (arrowhead)
and its larger C-terminal cleavage product (arrow). The bottom panel
shows the smaller C-terminal cleavage of SCC1-myc (arrow). Similar
results were obtained with the human peptide inhibitor Bio-DREIMR-
amk (data not shown).
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Figure 5. Securin Prevents Binding of Peptide Inhibitors to Separase
(A) Securin can rebind to activated separase. Separase immunoprecipitates (IP) from HeLa cells (lane 1) were incubated in mitotic Xenopus
extracts (lane 2). After reisolation, separase was incubated in the presence of buffer (lane 3), wild-type securin (WT, lane 4), a destruction box
mutant of securin (DB, lane 5), or BSA (lane 6) and was subsequently washed again. Aliquots were analyzed by immunoblotting with securin
(bottom panel) and C-terminal separase antibodies (top panel).
(B) Securin binding inhibits activated separase. Separase samples prepared as in (A) were analyzed in SCC1-myc cleavage assays as in Figure
3B. Full-length and cleaved SCC1-myc are marked by an arrowhead and an arrow, respectively.
(C) Securin prevents binding of peptide inhibitors to separase. Activated separase was incubated with securin (lane 1) or as a control with a
fragment of cyclin B (lane 2). Unbound proteins were washed away, and separase was incubated with 90 M Bio-DREIMR-amk, washed
again, and analyzed by blotting with avidin or with securin and separase antibodies. Alternatively, active separase was first incubated either
with peptide inhibitor (lane 3) or DMSO (lane 4) and was subsequently incubated with securin.
N-terminally FLAG-tagged separase with securin in M. Kirschner and colleagues (cited in [1]). We mutated
these sites by exchanging the position of the glutamateHeLa cells. FLAG immunoprecipitates were incubated
and the arginine residue with each other, because swap-in mitotic Xenopus extracts to allow securin destruction,
ping these residues in the SCC1 cleavage sites hadand the resulting separase cleavage fragments were
abolished cleavage completely [13]. To analyze theanalyzed by immunoblotting with FLAG antibodies and
cleavability of the mutants, we used an N-terminallywith antibodies to the C terminus of separase. Both N-
FLAG-tagged version of separase that contains a TEVand C-terminal fragments could clearly be detected in
protease recognition site between the tag and the firstthe immunoprecipitates, indicating that they remain
amino acid residue of separase. We coexpressed thisbound to each other after cleavage (Figure 6). Although
form of separase together with securin in HeLa cells,separase is cleaved at at least two sites, only a single
isolated it by FLAG immunoprecipitation, activated it in170-kDa band could be detected in the FLAG immu-
mitotic Xenopus extracts, and eluted it from the antibodynoblots. However, it is possible that the 170-kDa band
beads by incubation with TEV protease. We then ana-contains two N-terminal fragments of slightly different
lyzed different separase mutants for the presence oflengths that were not resolved by SDS-PAGE. Transfec-
C-terminal cleavage products by immunoblotting andtion of separase without securin confirmed the earlier
for their ability to cleave SCC1. We also analyzed theobservation [19] that securin is required for the accumu-
FLAG immunoprecipitates by immunoblotting with sec-lation of separase (Figure 6).
urin antibodies, which revealed that securin bound to
all mutants of separase equally well and that securin
Separase Cleavage Is Not Essential was effectively destroyed in mitotic Xenopus extracts
for SCC1 Cleavage in all cases (Figure S3).
To address whether separase cleavage is required for A mutant in which ELLR1535 was changed to RLLE1535
its activation, we first mapped the cleavage sites in was still cleaved at the first site, but cleavage at the
separase. We generated a series of N-terminal deletion second was almost completely abolished, confirming
mutants of separase and compared their electrophoretic that separase is normally cleaved at ELLR1535 (Figure
mobilities to those of the C-terminal separase cleavage 7B, lane 6). In contrast, a mutant in which EILR1506 was
fragments. This identified the sequences EILR1506 and changed to RILE1506 was still cleavable at two sites (Fig-
ELLR1535 as putative cleavage sites in which cleavage ure 7B, lane 3). The shorter C-terminal fragment ap-
would occur after the arginine residues (Figures 7A and peared unchanged in this mutant, but the longer one
migrated more slowly than its wild-type counterpart,S2). These sites were also independently identified by
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We also generated mutants in which the putative ac-
tive site cysteine2029 was mutated to alanine, and a
mutant in which serine1126 was changed to alanine. Stem-
mann and colleagues [25] had shown that phosphoryla-
tion of serine1126 inhibits separase. We found that sepa-
raseS1126A was cleaved to the same degree as wild-type
separase and also showed similar SCC1 cleavage activ-
ity (see below), suggesting that separase was not sub-
ject to inhibitory phosphorylation under our isolation
and assay conditions. In contrast, separaseC2029A did not
yield any cleavage products and was unable to cleave
SCC1, and this confirmed that cysteine2029 is critical for
protease activity (Figures 7B and 7C).
When we tested the different separase mutants in
SCC1 cleavage assays, we did not observe obvious
differences in their activity, with the exception of sepa-
raseC2029A, which was inactive (Figure 7C). Because lim-
iting amounts of the substrate SCC1 were used in this
assay, we performed a dose-response experiment with
the same amount of SCC1 and varying amounts of either
wild-type separase or the EIMR1486-EILR1506-ELLR1535 tri-
ple mutant. Also under these conditions, in which sepa-
rase activity was limiting, no differences between the
activities of wild-type and mutant separase could be
detected (Figure 7D). These results suggest that SCC1
cleavage by separase does not depend on the cleavage
of separase.
Separase Cleavage Occurs AutocatalyticallyFigure 6. N- and C-Terminal Separase Fragments Remain Associ-
During the course of our experiments, we made a num-ated with Each Other
ber of observations that suggest that separase cleavageExtracts of HeLa cells expressing N-terminally FLAG-tagged sepa-
occurs autocatalytically. First, we noticed that inhibitionrase, myc-tagged securin, or both were used for immunoprecipita-
tion with anti-FLAG antibodies. The immunoprecipitates were ana- of separase by peptide derivatives inhibited separase
lyzed by immunoblotting with FLAG, securin, and C-terminal cleavage (Figures 4A and 4B, lanes 5, and S1). Second,
separase antibodies before () and after () incubation in mitotic rebinding of securin to activated separase also corre-
Xenopus extracts. Full-length separase is marked by an arrowhead, lated with a slight decrease in the abundance of cleaved
an N-terminal cleavage product is marked by an arrow, and IgG
separase (Figure 5C, upper panel, compare lanes 1 andchains are marked by stars. Two proteins that bind nonspecifically
2). Third, all three cleavage sites that we identified into the antibody beads in Xenopus extracts and are recognized in
FLAG immunoblot reactions are indicated by bars. separase contain the consensus ExxR, which is also
found in the cleavage sites of known separase sub-
strates (Figure 7A). Finally, we observed that in vitro-and this suggests that cleavage had now occurred after
translated separase can be cleaved by active separasea residue other than 1506. Inspection of sequences up-
isolated from HeLa cells (Figure S4). Together, thesestream of EILR1506 identified another putative cleavage
observations indicate that separase cleaves itself oncesite, EIMR1486. Mutation of this site together with muta-
it has been activated by securin destruction. Recently,tion of the other two sites abolished separase cleavage
Stemmann et al. also reported autocatalytic cleavagealmost completely (Figure 7B, lane 5). These observa-
of separase [25].tions suggest that separase is normally cleaved at
ELLR1506 and ELLR1535, but that mutation of the first of
these sites results in cleavage at the more upstream Discussion
site, EIMR1486. Long immunoblot exposures revealed that
some fragments could still be detected in EIMR1486- Genetic and biochemical observations in different or-
ganisms indicate that sister chromatid separation is initi-EILR1506-ELLR1535 triple mutants (Figure 7A, lane 5), and
the presence of these fragments implies that some ated by the protease separase, which dissolves cohe-
sion between sister chromatids by cleaving cohesin.cleavage of the triple mutant may still occur, albeit at
very low levels. We furthermore observed one additional Our work further supports this model by showing that
inhibition of separase expression in human cells causesband that was migrating more slowly than the fragment
generated by cleavage after the very first site, EIMR1486 phenotypes in interphase and mitosis that are consistent
with an essential role of separase in anaphase. We ob-(Figure 7B, marked by a dot in lane 4). This band disap-
peared following treatment of separase samples with served that HeLa cells lacking physiological amounts of
separase become polyploid and form unusually large-protein phosphatase, indicating that it might represent
a phospho-isoform and not a distinct cleavage product and lobed nuclei, suggesting that they were able to
rereplicate their DNA but failed to undergo proper mito-(data not shown).
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Figure 7. Noncleavable Separase Can Cleave
SCC1
(A) Sequence alignment of cleavage sites in
human separase and known separase sub-
strates in humans (Hs), budding yeast (Sc),
and fission yeast (Sp). The arrow indicates the
arginine residue after which cleavage occurs.
“x” represents any amino acid residue.
(B) Isolation of recombinant soluble forms of
wild-type (WT) and mutated separase. Ex-
tracts of HeLa cells coexpressing securin and
different forms of FLAG-TEV-separase were
used for immunoprecipitation with anti-FLAG
antibodies. After incubation in mitotic Xeno-
pus extracts, separase was eluted with TEV
protease and was analyzed by immunoblot-
ting with antibodies to its C terminus. Full-
length separase is marked by an arrowhead,
three different C-terminal separase cleavage
fragments are marked by bars, and a phos-
phorylated isoform of a C-terminal fragment
is marked by a dot.
(C) The activities of wild-type and mutated
forms of separase isolated as in (B) were ana-
lyzed in SCC1-myc cleavage assays as in Fig-
ure 3B. Full-length SCC1-myc is marked by
an arrowhead, and C-terminal cleavage frag-
ments are marked by arrows.
(D) Titration of wild-type and noncleavable
separase in SCC1-myc cleavage assays.
Wild-type and noncleavable separase were
isolated as in (B) and were analyzed by immu-
noblotting with C-terminal separase antibod-
ies (left panel). Different amounts of the sep-
arase preparations were used in SCC1-myc
cleavage assays (right panel).
sis and cytokinesis. Consistent with this interpretation, matid cohesion could not be resolved in these chromo-
somes. As a consequence, these chromosomes maypolyploid cells have also been observed in yeast and
Drosophila cells containing mutant alleles of separase have been grouped together more closely because they
were subject to increased spindle pulling forces in ana-[6, 8, 27, 28] and in human cells expressing noncleavable
cohesin mutants [13]. phase. Alternatively, it is possible that loss of separase
expression had effects on spindle function, although,We further observed that chromosome spreads from
separase knockdown cells contained abnormal meta- so far, we have been unable to detect obvious spindle
defects by immunofluorescence microscopy (data notphase-like figures. Chromosomes were often arranged
in groups that were smaller than normal metaphase shown). Importantly, we observed numerous chromo-
some figures in which unseparated sister chromatidsplates. We presently do not know the molecular cause
of this phenotype, but it is conceivable that sister chro- had begun to decondense, suggesting that they were
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derived from cells that were exiting mitosis without hav-
ing separated their sister chromatids.
We performed our RNA interference experiments in
HeLa cells, which are unable to arrest in G1 in the pres-
ence of a tetraploid or polyploid DNA content and there-
fore continue to rereplicate their DNA. If loss of separase
expression caused a defect in sister chromatid sepa-
ration, one would expect to observe chromosomes con-
taining four chromatids (diplochromosomes) in these
cells. Such chromosomes have been observed in sepa-
rase-defective Drosophila mutants [8, 18], whereas sep-
arase mutants in other organisms have not been ana-
lyzed for the presence of diplochromosomes yet. To
our surprise, we have so far been unable to observe
diplochromosomes in separase knockdown cells. Low
but significant numbers of diplochromosomes have been
found in HeLa cells expressing noncleavable cohesin, but,
unexpectedly, these showed only some cohesion along
chromosome arms and not at centromeres, where sister
chromatids are normally tightly held together in meta-
phase [13]. One possible explanation for these conflict-
ing observations is that separase is required for the
timely resolution of sister chromatid cohesion at the
onset of anaphase but that sisters can nevertheless be
Figure 8. A Model Illustrating How Securin Destruction May Activateseparated from each other by an unknown mechanism
Separasein the subsequent interphase, perhaps during DNA repli-
The model proposes that securin inhibits separase by shieldingcation. In this respect, it would be interesting to analyze
its active site. Securin destruction mediated by the APC and the
if diplochromosomes in Drosophila separase mutants proteasome would therefore allow access of substrates to sepa-
contain fully replicated DNA, or if centromeres were not rase’s active site and would result in autocatalytic cleavage of sepa-
replicated in this case. rase into fragments that remain bound to each other. Both full-
length and cleaved separase may be able to cleave cohesin and toExpression of noncleavable cohesin often blocks sis-
initiate sister chromatid separation. It is not yet known to whichter chromatid separation without inhibiting the initiation
parts of human separase securin binds, but data in budding yeastof cytokinesis, resulting in a “cut” phenotype [13]. Sur-
suggest that securin can bind to both the evolutionary conserved
prisingly, we did not observe any cells with this pheno- C terminus of separase (shown in orange) and to nonconserved
type after inhibition of separase expression. We pres- N-terminal regions [29]. In Drosophila, the securin Pimples binds to
ently do not know if this difference is due to technical the separase C terminus and to Three-rows, which may correspond
to the N terminus of separase in other organisms [8, 35].aspects; for example, differences in the strength of phe-
notypes obtained by separase RNAi and by expression
of noncleavable cohesin, or if the difference is due to
can be inhibited by the insertion of inhibitor of apoptosisadditional functions of separase. For example, the differ-
(IAP) proteins into the active site of caspases [30, 31].ence in phenotype could be explained by the existence
It is therefore possible that securin is a noncleavableof additional separase substrates whose cleavage is
pseudosubstrate that inhibits separase by directly bind-required for the initiation of cytokinesis.
ing to its active site.
This interpretation does not imply, however, that sec-
urin does only bind to the active site and not to otherHow Does Securin Destruction Activate Separase?
Several observations have shown that securin proteoly- regions of separase. In fission yeast, the securin Cut2
has been shown to bind to an N-terminal part of sepa-sis is essential for separase activation, but it has so far
been unknown how securin inhibits separase and how rase [32], and, in budding yeast, Pds1 interacts with both
the N- and C-terminal parts of separase [29]. Likewise,securin destruction relieves this inhibition. Our biochem-
ical experiments with peptide inhibitors suggest that Drosophila Pimples has been shown to bind to both
Three-rows and separase, and this binding is consistentsecurin inhibits separase by preventing the access of
substrates to the active site of separase (Figure 8). Dur- with the possibility that Three-rows corresponds to an
N-terminal portion of separase in other organisms [8].ing preparation of this manuscript, Hornig et al. also
reported that securin prevents the binding of substrates Furthermore, we observed that securin can still bind to
separase, whose catalytic site had been occupied byto separase in budding yeast [29]. We do not yet know
if securin shields separase’s active site directly or if it a peptide inhibitor, also suggesting that securin can
interact with separase regions outside the active site.induces a conformational change in separase that blocks
substrate access indirectly. If the latter possibility were Our finding that peptide inhibitors can bind to the
active site of full-length separase only if the inhibitor istrue, the securin-induced conformational change had to
be reversible because we observed that securin is able present during securin degradation implies that securin
proteolysis uncovers the active site of separase thatto reinhibit already-activated separase. We further note
that caspases, which are distantly related to separase, then rapidly cleaves itself. This cleavage reaction nor-
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mally occurs at either one of two sites. However, if the Conclusions
Our separase siRNA experiments suggest that separasefirst of these is mutated, a third site further upstream
can also be used, as if separase “searches” for a cleavable function is required for sister chromatid separation dur-
ing mitosis in human cells. Our data are consistent withsite nearby if the usual site is changed in its sequence.
This implies that both the amino acid sequence around the idea that securin prevents access of substrates to
the active site of separase. Upon release of its inhibitorthe cleavage site and its position within the protein are
important determinants of autocatalytic cleavage. securin, separase cleaves itself at one of three potential
sites into fragments that remain noncovalently associ-
ated with each other. As separase cleavage is not essen-
Why Is Human Separase Cleaved? tial for its activation in vitro, it is conceivable that sepa-
Active preparations of separase contain predominantly rase cleavage prepares the enzyme for its subsequent
cleaved separase. Only these, and not the residual inactivation.
amounts of full-length separase that are also present,
Supplementary Materialcan be labeled with peptide inhibitors, indicating that
Supplementary Material including the Experimental Procedures andcleaved separase must be an active protease, whereas
additional data about separase cleavage and cloning of full-lengthfull-length separase in these preparations may still be
separase is available at http://images.cellpress.com/supmat/
bound and inhibited by securin. This notion is also sup- supmatin.htm.
ported by the observation that separase cleavage coin-
cides with cohesin cleavage in vivo, which is in line with Acknowledgments
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